State Taxes on Student-Debt Relief Would Hit Black Borrowers Hardest

日本 ニュース ニュース

State Taxes on Student-Debt Relief Would Hit Black Borrowers Hardest
日本 最新ニュース,日本 見出し
  • 📰 TIME
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 53%

Several states may end up taxing that relief, creating a situation where borrowers have to make a payment of as much as $1,000 in the near term as a result of getting the long-term financial benefit of cancellation

President Joe Biden delivers remarks on Student Debt Relief at Delaware State University in Dover, on October 21, 2022.or some borrowers, the impact of the White House’s student-debt forgiveness program may be influenced by the interpretation and implementation of tax law.that relief, creating a situation where borrowers have to make a payment of as much as $1,000 in the near term as a result of getting the long-term financial benefit of cancellation. On Nov.

More importantly, there’s this legal doctrine that says you can’t sue on any issue if you don’t have something called standing, which means there’s a specific harm you are alleging. There are longstanding cases that basically say you can’t sue as a taxpayer just because your taxes are going to go up. Because if that was the case, you could imagine the lawsuits against the 2017 Trump tax cuts. The argument that “I’m having my taxes go up” flies in the face of lots of precedent.

It’s true 56% of Black Americans live in the South. But of the population whose debt is being forgiven in the South, what’s that racial demographic? That’s what I’d want to know. How many Black borrowers are getting this debt relief and currently living in the South? Are we seeing the Black college grads living someplace else?

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

TIME /  🏆 93. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Windfall taxes: good politics, tricky policy\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
続きを読む »

Windfall taxes: good politics, tricky policy\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
続きを読む »

Duelling US presidents descend on key swing state PennsylvaniaDuelling US presidents descend on key swing state PennsylvaniaTrump, Obama and Biden all rally in Pennsylvania, urging Americans to vote in the midterm elections.
続きを読む »

Drugging KRAS: current perspectives and state-of-art review - Journal of Hematology & OncologyDrugging KRAS: current perspectives and state-of-art review - Journal of Hematology & OncologyAfter decades of efforts, we have recently made progress into targeting KRAS mutations in several malignancies. Known as the ‘holy grail’ of targeted cancer therapies, KRAS is the most frequently mutated oncogene in human malignancies. Under normal conditions, KRAS shuttles between the GDP-bound ‘off’ state and the GTP-bound ‘on’ state. Mutant KRAS is constitutively activated and leads to persistent downstream signaling and oncogenesis. In 2013, improved understanding of KRAS biology and newer drug designing technologies led to the crucial discovery of a cysteine drug-binding pocket in GDP-bound mutant KRAS G12C protein. Covalent inhibitors that block mutant KRAS G12C were successfully developed and sotorasib was the first KRAS G12C inhibitor to be approved, with several more in the pipeline. Simultaneously, effects of KRAS mutations on tumour microenvironment were also discovered, partly owing to the universal use of immune checkpoint inhibitors. In this review, we discuss the discovery, biology, and function of KRAS in human malignancies. We also discuss the relationship between KRAS mutations and the tumour microenvironment, and therapeutic strategies to target KRAS. Finally, we review the current clinical evidence and ongoing clinical trials of novel agents targeting KRAS and shine light on resistance pathways known so far.
続きを読む »

Meet the student bringing street food to Co DownMeet the student bringing street food to Co DownPeople have travelled from Dublin to try out the dishes
続きを読む »



Render Time: 2025-02-24 15:33:19